Neuronet convenes 8th meeting of its Scientific Coordination Board
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
EMIF
Neuronet hosts meetings of its Patient Privacy & Ethics and Data Sharing working groups
Neuronet is an Innovative Medicines Initiative (IMI)-funded coordination and support action, designed to support and
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
Spotlight on early-career researchers: a Neuronet interview with Alexander Neumann
Alex studies the genetics of Alzheimer’s disease biomarkers, by examining rare genetic variants obtained from whole exome sequencing.
Tools for federated Electronic Health Record analyses
The European Medical Information Framework (EMIF)-Platform has leveraged data on more then 62 Million European
Characteristics of subjective cognitive decline associated with amyloid positivity
Introduction The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Improving the identification, access and assessment, and (re)use of health data within the European Union
During its project lifetime, the European Medical Information Framework (EMIF) has developed and made the
Neuronet Working Groups emphasise the importance of effective collaboration to overcome obstacles linked to patient privacy and data sharing
As a coordination and support action, Neuronet has been designed to enhance the impact and
EMIF study shows that plasma biomarkers can predict the presence of Alzheimer’s disease pathology in the brain
When it comes to brain pathology, Alzheimer’s disease (AD) is defined by loss and gain: